You are viewing: North America Elastomeric Infusion Pumps Market analysis

The North America Elastomeric Infusion Pumps Market was valued at $540.8 Million in 2025 and projected to reach to $703.5 Million by 2030, representing a compound annual growth rate of 5.4%. North America's elastomeric infusion pumps market is poised for steady expansion through 2030, driven by increasing prevalence of chronic diseases, growing demand for home-based infusion therapy, and technological advancements in drug delivery systems.

North America Elastomeric Infusion Pumps Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Elastomeric Infusion Pumps Market Trends and Insights

  • North America maintains a significant share of the global elastomeric infusion pumps market, driven by advanced healthcare infrastructure, high adoption of innovative drug delivery systems, and strong regulatory frameworks.
  • The region's market growth is supported by increasing prevalence of chronic diseases, rising demand for portable and patient-friendly infusion solutions, and substantial investments in medical device innovation. Throughout the forecast period from 2025 to 2030, North America is expected to benefit from expanding home healthcare services and growing preference for elastomeric pumps over traditional IV systems.
  • North America's competitive landscape features established medical device manufacturers and emerging innovators focused on enhancing pump efficiency, safety features, and ease of use.
  • The region's robust reimbursement policies and healthcare spending further accelerate market penetration across hospitals, clinics, and home care settings..

Key Market Statistics

  • CAGR (2025-2030) 5.4% CAGR
  • Market Size, 2025 ~USD 540.8 Million
  • Forecast, 2030 ~USD 703.5 Million
  • Geography North America

North America Elastomeric Infusion Pumps Market Overview

Market Valuation & Growth :

North America's elastomeric infusion pumps market is valued at $540.8 million in 2025 and is projected to reach $703.5 million by 2030, with a CAGR of 5.4%, outpacing the global growth rate of 5.3%.

US Market Dominance :

The United States represents the largest market within North America at $660 million, accounting for the majority of regional demand driven by advanced healthcare infrastructure and high adoption of innovative drug delivery technologies.

Healthcare Infrastructure Advantage :

North America benefits from robust regulatory frameworks, established reimbursement policies, and strong healthcare spending, creating favorable conditions for elastomeric infusion pump adoption across clinical and home care settings.

Regional Market Composition :

Canada ($24.2 million) and Mexico ($19.3 million) contribute to the regional market, with North America collectively representing a significant portion of global elastomeric infusion pump demand.

North America Elastomeric Infusion Pumps Market Dynamics

  • The region's mature healthcare infrastructure and strong regulatory support create a favorable environment for market growth.
  • Healthcare providers and pharmaceutical companies are increasingly adopting elastomeric pumps due to their cost-effectiveness, ease of use, and improved patient compliance compared to traditional infusion methods. The market will be further supported by rising geriatric populations requiring long-term medication management and expanding clinical applications across oncology, immunology, and pain management.
  • Strategic partnerships between device manufacturers and healthcare systems, coupled with growing reimbursement coverage, will accelerate market penetration.
  • North America's emphasis on patient-centric care and home healthcare solutions positions the region for sustained growth at a 5.4% CAGR through 2030..

Related Ecosystem

Key Takeaways

  • North America's elastomeric infusion pumps market is valued at $540.8 million in 2025 and will reach $703.5 million by 2030, growing at 5.4% CAGR.
  • North America benefits from advanced healthcare infrastructure, strong regulatory frameworks, and high adoption of innovative drug delivery technologies.
  • North America's market growth is driven by increasing chronic disease prevalence, expanding home healthcare services, and growing preference for portable infusion solutions.
  • North America's robust reimbursement policies and competitive landscape of established and emerging manufacturers support sustained market expansion through 2030.

Elastomeric Infusion Pumps Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment HOME CARE SETTINGS (Setting)
Forecast Period 2025–2030
Growth Rate CAGR of 5.3% from 2025 to 2030
Largest Segment ACCESSORIES AND CONSUMABLES (Product)
Market Size Base Year (Billions) ~USD 1.15 (2025)
Revenue Forecast (Billions) ~USD 1.49 (2030)
Segments Covered Type, Application, End-Use Industry, Product, Setting

North America Elastomeric Infusion Pumps Market Report Segmentation

5 segment dimensions are covered across the global market.

By Type

  • Continuous Rate
  • Variable Rate

By Application

  • Analgesia/Pain Management
  • Antibiotics
  • Chemotherapy
  • Chemotherapy/Oncology
  • Diabetes Management
  • Gastroenterology
  • Hematology
  • Other Applications
  • Pain Management
  • Pediatrics/Neonatology

By End-Use Industry

  • Ambulatory Surgical Centers (Ascs)
  • Homecare Settings
  • Hospitals
  • Other End-Use Industries

By Product

  • Accessories And Consumables
  • Devices

By Setting

  • Academic And Research Institutes
  • Ambulatory Care Settings
  • Home Care Settings
  • Hospitals

Target Audience

  • Medical Device Manufacturers : Manufacturers need North America-specific market data to optimize product positioning, identify growth opportunities, and develop region-tailored commercialization strategies for elastomeric infusion pumps.
  • Healthcare Providers & Hospital Systems : Hospital networks and healthcare systems require market insights to evaluate infusion pump adoption trends, benchmark procurement decisions, and plan capital investments in drug delivery infrastructure.
  • Pharmaceutical Companies : Pharma firms need understanding of North America's infusion pump market to align drug delivery strategies, support clinical trial planning, and optimize patient access programs for injectable medications.
  • Investment & Private Equity Firms : Investors require detailed North America market analysis to evaluate acquisition targets, assess portfolio company growth potential, and identify emerging opportunities in the medical device sector.
  • Healthcare Consultants & Analysts : Consultants and research analysts need comprehensive regional data to support client advisory work, competitive benchmarking, and strategic planning in the elastomeric infusion pump market.

Key Companies in the North America Elastomeric Infusion Pumps Market

CompanyHQOwnershipStrongest segments
BAXTERUnited StatesPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
NIPROJapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
AVNSUnited StatesPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
WOOYOUNG MEDICAL CO., LTD.South KoreaPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Electronic Infusion Pumps (adjacent),
SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.ChinaPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Accessories & Disposables for Elastomeric Pumps,
AMBU A/SDenmarkPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
DAIKEN MEDICAL CO., LTD.JapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate / PCA Elastomeric Pumps,Chemotherapy Applications,

BAXTER

Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates in the medical devices and pharmaceuticals sector.

NIPRO

Nipro is a Japanese public company founded in 1947 with 38,593 employees operating in the medical devices sector. The company serves global healthcare markets.

AVNS

AVNS is a privately held American company founded in 2014 with 2,287 employees. The company operates in the medical devices industry.

WOOYOUNG MEDICAL CO., LTD.

Wooyoung Medical Co., Ltd. is a privately held South Korean company founded in 1996. The company operates in the medical devices sector.

SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.

Shanghai Int Medical Instruments Co., Ltd. is a publicly traded Chinese medical device company founded in 2006 with 2,088 employees. The company serves the healthcare market.

AMBU A/S

Ambu A/S is a publicly traded Danish medical device company founded in 1937 with 5,200 employees. The company specializes in emergency and surgical equipment.

DAIKEN MEDICAL CO., LTD.

Daiken Medical Co., Ltd. is a publicly traded Japanese medical device company founded in 1968 with 185 employees. The company serves the healthcare industry.

North America vs. other regions

HowNorth America compares to the other 3 regional blocs covered in this market.

Europe
~USD 380.4 Million · 5% wtd CAGR ·
Asia Pacific
~USD 327.3 Million · 5.7% wtd CAGR ·
Middle East & Africa
~USD 27.9 Million · 4.2% wtd CAGR ·
South America
~USD 49.5 Million · 4.4% wtd CAGR ·

Countries within North America - compare and drill down

Country2025 size (native)
USUSD 660 Million
CanadaUSD 24.2 Million
MexicoUSD 19.3 Million

Country market size visualization

US
USD 660 Million
Canada
USD 24.2 Million
Mexico
USD 19.3 Million

Reasons to Buy this Report

  • Regional Market Sizing & Forecasts : Obtain precise market valuations for North America ($540.8M in 2025) and country-level breakdowns for the US, Canada, and Mexico with detailed 5-year projections through 2030.
  • Competitive Landscape Analysis : Understand market dynamics specific to North America, including key players, market share distribution, and competitive strategies tailored to the region's regulatory and reimbursement environment.
  • Growth Driver Identification : Identify North America-specific growth catalysts including healthcare infrastructure advantages, regulatory support, reimbursement trends, and adoption patterns driving the 5.4% CAGR.
  • Strategic Market Entry & Expansion : Develop informed market entry strategies and expansion plans with country-specific insights for the US, Canada, and Mexico, including market gaps and opportunity areas.
  • Investment & Business Decision Support : Make data-driven investment, partnership, and acquisition decisions backed by comprehensive North America market intelligence and forward-looking forecasts through 2030.

Frequently asked questions

What is the current market size of elastomeric infusion pumps in North America?

North America's elastomeric infusion pumps market is valued at $540.8 million in 2025 and is expected to grow to $703.5 million by 2030.

What is the projected growth rate for elastomeric infusion pumps in North America?

North America's elastomeric infusion pumps market is projected to grow at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2030.

What factors are driving growth in North America's elastomeric infusion pumps market?

North America's market growth is driven by advanced healthcare infrastructure, increasing chronic disease prevalence, expanding home healthcare services, strong reimbursement policies, and rising demand for portable and patient-friendly infusion solutions.

How does North America's elastomeric infusion pumps market compare to other regions?

North America maintains a significant share of the global elastomeric infusion pumps market due to its advanced healthcare system, strong regulatory frameworks, high adoption of innovative technologies, and robust medical device manufacturing ecosystem.

What are the key applications of elastomeric infusion pumps in North America?

In North America, elastomeric infusion pumps are widely used in hospitals, clinics, and home care settings for delivering medications, chemotherapy, antibiotics, and other therapeutic agents, with growing adoption in portable and patient-controlled infusion therapies.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the global elastomeric infusion pumps market. Exhaustive secondary research was conducted to gather information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of elastomeric infusion pumps through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the elastomeric infusion pumps market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

The market for companies offering elastomeric infusion pumps is determined by secondary data obtained from paid and unpaid sources, analyzing the product portfolios of major companies in the ecosystem, and evaluating companies based on their performance and quality. Various secondary sources, including Business Standard, Bloomberg, the World Bank, and Factiva, were consulted to identify and collect information for this study on the elastomeric infusion pumps market. During the secondary research process, various secondary sources were consulted to identify and collect information relevant to the study. Secondary sources included annual reports, press releases, investor presentations of door vendors, forums, certified publications, and white papers. The secondary research was utilized to gather critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from both market- and technology-oriented perspectives.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the elastomeric infusion pump market. After completing the market engineering process (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of elastomeric infusion pumps offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

The following is the breakdown of primary respondents:

Elastomeric Infusion Pumps Market

Notes: Other designations include sales, marketing, and product managers. Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were employed to estimate and validate the size of the global elastomeric infusion pumps market. These methods were also widely used to assess the size of various related market segments. The research methodology used to determine the market size included the following:

Elastomeric Infusion Pumps Market

Data Triangulation

After determining the overall market size using market size estimation processes, the market was segmented into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Elastomeric infusion pumps are portable, non-electronic medical devices designed for the controlled delivery of drugs, such as analgesics, antibiotics, and chemotherapeutic agents, over a specified period. These devices utilize the elastic properties of specific elastomers to deliver accurate, continuous, or intermittent medication infusions without requiring batteries or external power sources. Elastomeric infusion pumps are recognized for their simplicity, reliability, and ease of use, making them suitable for use in hospital, outpatient, and home care environments. They are produced and tested in accordance with international medical device standards, including ISO 13485 for quality management, ISO 11608 for infusion device efficacy, and ASTM standards for elastomeric materials. The devices are extensively utilized in oncology, pain management, anesthesia, and palliative care, enhancing patient compliance, mobility, and safety. Elastomeric infusion pumps are crucial to the advancement of the field of patient-centered drug delivery and healthcare innovation, particularly in home healthcare and ambulatory care.

Stakeholders

  • Elastomeric infusion pump manufacturers
  • Raw material suppliers
  • Converters & processors
  • Distributors and traders
  • Industry associations and regulatory bodies
  • End users

Report Objectives

  • To define, describe, and forecast the size of the global elastomeric infusion pumps market, based on type, end-use industry, and region in terms of value and volume
  • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
  • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
  • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • To analyze competitive developments such as acquisitions, expansions, partnerships, and agreements in the elastomeric infusion pumps market
  • To provide the impact of AI/Gen AI on the market

Get the Full Elastomeric Infusion Pumps Market Report

Full forecast, segment splits, and company analysis for all Elastomeric Infusion Pumps Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status